CMS defines 96372 as subcutaneous or intramuscular injection administration not the medication itself
In addition, enhanced insulin secretion improves cardiac function and increase inotropy, regulate blood flow to myocardial tissue, and exerts anti-inflammatory, antioxidant, and antiapoptotic effects (Ng et al
If so, you have NAFLD or NASH
No lethal dose has been established in animal studies, even at dosages many orders of magnitude higher than those used in therapeutic research
The guideline language addresses therapeutic GH, not secretagogues, but the mechanistic concern is parallel
Seungpyo Hong and Ryan Pearson for helpful discussions of experiments for this manuscript